Pediatricians screen and refer children for behavioral health Childhood and adolescence are critical periods in development
Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant Data Published in BMC Veterinary Research shows that OKV-119 exenatide implant reduced feline weight Felines share many pathophysiologic obesity phenotypes with humans, further supporting clinical evaluations of miniature, subdermal GLP-1 implants for obesity reduction Development partner, Okava Pharmaceuticals, is studying OKV-119 for the treatment of pre-diabetes, diabetes, and obesity in companion felines ALAMEDA, Calif.--(BUSINESS WIRE)-- Vivani Medical, Inc
BG: Software, Supervision, Validation, Visualization, Writing - original draft, Writing review & editing
TCM approaches have demonstrated significant clinical efficacy as complementary therapeutic modalities
Shipping time depends on your delivery address